comparemela.com

Latest Breaking News On - Tokyo stock exchange growth - Page 1 : comparemela.com

Modalis Therapeutics Reports Data Supporting Development of a Transformative Epigenome Editing Therapeutic, MDL-101: a First-in-Class Epigenome Editing approach for the Treatment of LAMA2-deficient congenital muscular dystrophy (LAMA2-CMD)

A breakthrough approach and supporting data using epigenome editing technology for the treatment of a type of muscular dystrophy, LAMA2-congenital muscular dystrophy , a genetic disorder, is.

FRONTEO : Established Novel Targets Library to introduce target genes with novelty and high potential -April 08, 2024 at 02:16 am EDT

Soracom Listed on the Tokyo Stock Exchange Growth Market

Soracom, Inc., a global provider of advanced connectivity for the Internet of Things (IoT), today announced that it has listed its shares on the Growth Market of the Tokyo Stock Exchange. Soracom currently connects millions of devices worldwide,.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.